Meridian Bioscience Launches Lyo-Ready qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection
CINCINNATI, March 29, 2022 /PRNewswire/ — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new master mixes that detect DNA and RNA in crude blood samples down to a single copy – enabling the earliest detection of cancer using non-invasive liquid biopsy. […]